117 related articles for article (PubMed ID: 35619282)
1. Ursodeoxycholic Acid (UDCA) Reduces Hepatocyte Apoptosis by Inhibiting Farnesoid X Receptor (FXR) in Hemorrhagic Shock (HS).
Wang L; Rui X; He HW; Zhou X; Long Y
Curr Mol Med; 2023; 23(6):550-558. PubMed ID: 35619282
[TBL] [Abstract][Full Text] [Related]
2. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3].
Ji WJ; Qu Q; Jin Y; Zhao L; He XD
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712
[TBL] [Abstract][Full Text] [Related]
3. TUDCA Ameliorates Liver Injury Via Activation of SIRT1-FXR Signaling in a Rat Hemorrhagic Shock Model.
Sun S; Zhao B; Qi M; Yao Y; Xu L; Ji R; Chen W; Wang J; Huang S; Ma L; Chen Y; Yang Z; Sheng H; Fei J; Chen E; Mao E
Shock; 2020 Feb; 53(2):217-222. PubMed ID: 30998645
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic Acid (UDCA) Promotes Lactate Metabolism in Mouse Hepatocytes through Cholic Acid (CA) - Farnesoid X Receptor (FXR) Pathway.
Wang L; He HW; Zhou X; Long Y
Curr Mol Med; 2020; 20(8):661-666. PubMed ID: 31971110
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid abrogates gentamicin-induced hepatotoxicity in rats: Role of NF-κB-p65/TNF-α, Bax/Bcl-xl/Caspase-3, and eNOS/iNOS pathways.
Ali FEM; Hassanein EHM; Bakr AG; El-Shoura EAM; El-Gamal DA; Mahmoud AR; Abd-Elhamid TH
Life Sci; 2020 Aug; 254():117760. PubMed ID: 32418889
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist.
Fujita K; Iguchi Y; Une M; Watanabe S
Lipids; 2017 Apr; 52(4):335-344. PubMed ID: 28315136
[TBL] [Abstract][Full Text] [Related]
7. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats.
Oyama K; Shiota G; Ito H; Murawaki Y; Kawasaki H
Carcinogenesis; 2002 May; 23(5):885-92. PubMed ID: 12016164
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid loaded dual-modified graphene oxide nanocomposite alleviates cholestatic liver injury through inhibiting hepatocyte apoptosis.
Zhou W; Yang X; Yin Y; Chen S; Yang L; Li T; Liu J; Lu B; Yang Z; Li R; Zhang M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113904. PubMed ID: 38603845
[TBL] [Abstract][Full Text] [Related]
9. Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.
Wu YL; Li ZL; Zhang XB; Liu H
World J Gastroenterol; 2019 Nov; 25(41):6205-6221. PubMed ID: 31749592
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
[TBL] [Abstract][Full Text] [Related]
11. [Farnesoid-X-receptor blockade reduces myocardial reperfusion injury in cholesterol-fed apolipoprotein E knockout mice].
Tong H; Shan PR; Zhao YC; Yuan AC; He Q; Yao TB; Ying XY; Pu J; He B
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):642-6. PubMed ID: 24225234
[TBL] [Abstract][Full Text] [Related]
12. Effect of Beclin-1 gene silencing on autophagy and apoptosis of the prostatic hyperplasia epithelial cells.
Liu R; Zhang S; Wan R; Deng J; Fang W
Clinics (Sao Paulo); 2022; 77():100076. PubMed ID: 36088885
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
[TBL] [Abstract][Full Text] [Related]
14. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis.
Xu Y; Li D; Wu J; Zhang M; Shao X; Xu L; Tang L; Zhu M; Ni Z; Zhang M; Mou S
Cell Prolif; 2021 Apr; 54(4):e13005. PubMed ID: 33594777
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes.
Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM
J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686
[TBL] [Abstract][Full Text] [Related]
18. BML-111 inhibits the inflammatory response and apoptosis of renal tissue in rats with hemorrhagic shock by inhibiting the MAPK pathway.
Chang SY; Sun RQ; Feng M; Li YX; Wang HL; Xu YM
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3439-3447. PubMed ID: 29917196
[TBL] [Abstract][Full Text] [Related]
19. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
Pang L; Zhao X; Liu W; Deng J; Tan X; Qiu L
Nutrients; 2015 May; 7(5):3200-18. PubMed ID: 25951128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
